Johnson & Johnson Innovation LLC and Children’s National Health System (Children’s National) are collaborating to launch JLABS @ Washington, DC – a 32,000-square foot facility to be located at the new Children’s National Research and Innovation Campus in Washington, D.C. This Children’s National expansion is set on a nearly 12-acre portion of the former Walter Reed Army Medical Center campus in the nation’s capital. The co-location of the Research and Innovation Campus with key partners in the areas of public health research, innovation and incubator space is critical to accelerating the translation of potential breakthrough discoveries into new treatments and technologies. The JLABS @ Washington, DC site will be open to pharmaceutical, medical device, consumer and health technology companies that are aiming to advance the development of new drugs, medical devices, precision diagnostics and health technologies, including applications in pediatrics.

This collaboration marks the second time Johnson & Johnson and Children’s National have teamed up to emphasize the importance of investing in the health and well-being of babies and children around the world. Through either sponsorship or membership, both entities founded Safe Kids Worldwide, a nonprofit organization aiming to help families and communities keep kids safe from injuries.

“The vision we pursued for this campus required a global innovation partner with a strong commitment to pediatric health and a clear understanding of the next big areas of opportunity for improving human health. We believe the JLABS model is exactly what is needed to help us drive discoveries that are then rapidly translated into new treatments and technologies,” said Kurt Newman, M.D., president and Chief Executive Officer, Children’s National.

Children’s National leads the FDA-funded National Capital Consortium for Pediatric Device Innovation in collaboration with the University of Maryland, College Park. The consortium has provided mentorship support to more than 60 medical device startups to help advance their pediatric innovations. Five of the devices assisted by this program have received either CE Mark approval or FDA market clearance. Children’s National has also spun out more than 20 start-up companies from its own intellectual property.

Children’s National is currently ranked 7th in National Institutes of Health (NIH) research funding among pediatric hospitals. The new campus will allow Children’s National to expand its research programs. A key area of expansion when the campus opens will be high-impact opportunities in pediatric genomic and precision medicine, anchored by the organization’s Center for Genetic Medicine Research and Rare Disease Institute. Its proximity to federal research institutions and agencies, universities, and academic research centers enables the new Children’s National campus to leverage the ecosystem of the public and private sectors to help bolster innovation.

JLABS, in addition to offering emerging life science companies modular lab units, office space, shared core laboratory equipment and business facilities, will link the entrepreneurs within the district and across the greater Virginia and Maryland regions with the full breadth of the Johnson & Johnson Innovation model, including opportunities for funding, third-party services, educational events and R&D experts from medical technology, consumer healthcare product and Janssen pharmaceutical teams. In addition to providing access to scientific, industry and capital funding experts from across the industry, JLABS @ Washington, DC will also follow the same no-strings attached approach currently in operation in San Diego; San Francisco; South San Francisco; Boston; Lowell, MA; Houston; Toronto; New York City; Beerse, Belgium; and Shanghai, China (opening June 2019).

Global Head of Johnson & Johnson Innovation – JLABS, Melinda Richter said, “The JLABS’ no-strings-attached model aims to remove the barriers for startups by providing the resources they need without taking any equity or intellectual property and encourages collaboration by providing access to the world’s leading experts, executives, and funders to grow their companies. With JLABS @ Washington, DC housed at this one-of-a-kind facility for pediatric research, we complement the Children’s National’s mission while further strengthening and expanding the region’s network to encompass the full breadth of science and technology innovators who are focused on developing transformative solutions to improve lives. In this model, our goal is to provide a platform for innovators to be ‘heroes in their own hometown’ while enhancing and saving lives, including those of our most precious and vulnerable, all over the world.”